» Articles » PMID: 30131435

Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E

Abstract

Obesity is associated with cancer risk and its link with liver cancer is particularly strong. Obesity causes non-alcoholic fatty liver disease (NAFLD) that could progress to hepatocellular carcinoma (HCC). Chronic inflammation likely plays a key role. We carried out a bioassay in the high-fat diet (HFD)-fed C57BL/6J mice to provide insight into the mechanisms of obesity-related HCC by studying γ-OHPdG, a mutagenic DNA adduct derived from lipid peroxidation. In an 80-week bioassay, mice received a low-fat diet (LFD), high-fat diet (HFD), and HFD with 2% Theaphenon E (TE) (HFD+TE). HFD mice developed a 42% incidence of HCC and LFD mice a 16%. Remarkably, TE, a standardized green tea extract formulation, completely blocked HCC in HFD mice with a 0% incidence. γ-OHPdG measured in the hepatic DNA of mice fed HFD and HFD+TE showed its levels increased during the early stages of NAFLD in HFD mice and the increases were significantly suppressed by TE, correlating with the tumor data. Whole-exome sequencing showed an increased mutation load in the liver tumors of HFD mice with G>A and G>T as the predominant mutations, consistent with the report that γ-OHPdG induces G>A and G>T. Furthermore, the mutation loads were significantly reduced in HFD+TE mice, particularly G>T, the most common mutation in human HCC. These results demonstrate in a relevant model of obesity-induced HCC that γ-OHPdG formation during fatty liver disease may be an initiating event for accumulated mutations that leads to HCC and this process can be effectively inhibited by TE. .

Citing Articles

Detection of γ-OHPdG in Circulating Tumor Cells of Patients With Hepatocellular Carcinoma as a Potential Prognostic Biomarker of Recurrence.

Aggarwal M, Kuo M, Zhu Z, Gould S, Zhang K, Johnson P Gastro Hep Adv. 2024; 3(6):809-820.

PMID: 39280920 PMC: 11401592. DOI: 10.1016/j.gastha.2024.04.006.


Pyrroloquinoline quinone protects against murine hepatitis virus strain 3-induced fulminant hepatitis by inhibiting the Keap1/Nrf2 signaling.

Pu Z, Ge F, Zhou Y, Liu A, Yang C Cytotechnology. 2024; 76(4):441-452.

PMID: 38933874 PMC: 11196452. DOI: 10.1007/s10616-024-00627-0.


Ginsenoside Rg Activates the LKB1/AMPK/mTOR Signaling Pathway and Modifies the Gut Microbiota to Alleviate Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet.

Shi Y, Chen J, Qu D, Sun Q, Yu Y, Zhang H Nutrients. 2024; 16(6).

PMID: 38542753 PMC: 10974897. DOI: 10.3390/nu16060842.


Ablation of sphingosine kinase 2 suppresses fatty liver-associated hepatocellular carcinoma via downregulation of ceramide transfer protein.

Liu X, Chung L, Liu D, Chen J, Huang Y, Teo J Oncogenesis. 2022; 11(1):67.

PMID: 36333295 PMC: 9636415. DOI: 10.1038/s41389-022-00444-0.


Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical Aspects.

Okada F, Izutsu R, Goto K, Osaki M Cancers (Basel). 2021; 13(4).

PMID: 33671768 PMC: 7926701. DOI: 10.3390/cancers13040921.


References
1.
Emami A, Dyba M, Cheema A, Pan J, Nath R, Chung F . Detection of the acrolein-derived cyclic DNA adduct by a quantitative 32P-postlabeling/solid-phase extraction/HPLC method: blocking its artifact formation with glutathione. Anal Biochem. 2007; 374(1):163-72. PMC: 2275120. DOI: 10.1016/j.ab.2007.10.029. View

2.
Minko I, Washington M, Kanuri M, Prakash L, Prakash S, Lloyd R . Translesion synthesis past acrolein-derived DNA adduct, gamma -hydroxypropanodeoxyguanosine, by yeast and human DNA polymerase eta. J Biol Chem. 2002; 278(2):784-90. DOI: 10.1074/jbc.M207774200. View

3.
Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad I . Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012; 44(6):694-8. PMC: 3819251. DOI: 10.1038/ng.2256. View

4.
Kochi T, Shimizu M, Terakura D, Baba A, Ohno T, Kubota M . Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. Cancer Lett. 2013; 342(1):60-9. DOI: 10.1016/j.canlet.2013.08.031. View

5.
Halegoua-De Marzio D, Kraft W, Daskalakis C, Ying X, Hawke R, Navarro V . Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extract. Clin Ther. 2012; 34(12):2279-2285.e1. DOI: 10.1016/j.clinthera.2012.10.009. View